JPMORGAN CHASE & CO JPM-PL
NYSE · stock
2/9
Piotroski F — financial health
—
Altman Z″ — distress risk
29.1%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $182.4B | $57.0B | — | — | $362.4B |
| 2024 | $177.6B | $58.5B | — | — | $344.8B |
| 2023 | $158.1B | $49.6B | — | — | $327.9B |
| 2022 | $128.7B | $37.7B | — | — | $292.3B |
| 2021 | $121.6B | $48.3B | — | — | $294.1B |
| 2020 | $120.0B | $29.1B | — | — | $279.4B |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0000019617 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.